Shortcast: A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD
Oct 19, 2023•5 min
Episode description
Dr Claire Horgan discusses the first year of offering gene therapy to patients with metachromatic leukodystrophy (MLD) in the UK. When given in a timely fashion the impact is incredible but large numbers of children remain ineligible for treatment.
A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead
Claire Horgan, et al
https://doi.org/10.1002/jmd2.12378
For the best experience, listen in Metacast app for iOS or Android
